Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cyanotech Announces Financial Results Webcast February 2, 2004.


Business Editors/Health/Medical Writers

KAILUA KONA, Hawaii--(BUSINESS WIRE)--Jan. 16, 2004

Cyanotech Corporation (Nasdaq:CYAN), will announce financial results for fiscal year 2004 third quarter (ended December 31, 2003) after the market closes on Monday, February 2, 2004.

Company management will host a conference call at 5:30 p.m. Eastern Time to discuss the financial results.

Webcast

This call is being webcast and is available at http://www.vcall.com and on Cyanotech's website, http://www.cyanotech.com. To access the simultaneous webcast, select the Recent News section from Cyanotech's home page. Click on the announcement entitled, "Cyanotech Announces Financial Results Webcast February 2, 2004."

Archive

An archive of the webcast will be available on the home page and the investor relations Investor relations

The process by which the corporation communicates with its investors.
 page of the Cyanotech website.

Submit Questions

In advance of the conference call, Cyanotech welcomes individual investors to submit their questions via email to lguerrant@guerrantir.com. The company will address as many questions as possible.

About Cyanotech

Cyanotech Corporation, a world leader in microalgal technology, produces high-value natural products from microalgae and is the world's largest commercial producer of natural astaxanthin (pronounced "asta-zan-thin") from microalgae. Products include BioAstin(R) natural astaxanthin, a powerful antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene  with expanding applications as a human nutraceutical nu·tra·ceu·ti·cal
n.
A food or naturally occurring food supplement thought to have a beneficial effect on human health.


nutraceutical
; NatuRose(R) natural astaxanthin for the aquaculture aquaculture, the raising and harvesting of fresh- and saltwater plants and animals. The most economically important form of aquaculture is fish farming, an industry that accounts for an ever increasing share of world fisheries production.  and animal feed industries; Spirulina spirulina

Any cyanobacteria in the genus Spirulina. A traditional food source in parts of Africa and Mexico, spirulina is an exceptionally rich source of vitamins, minerals, and protein, and one of the few nonanimal sources of vitamin B12.
 Pacifica(R), a nutrient-rich dietary supplement Noun 1. dietary supplement - something added to complete a diet or to make up for a dietary deficiency
diet - a prescribed selection of foods

vitamin pill - a pill containing one or more vitamins; taken as a dietary supplement
; and phycobiliproteins, which are fluorescent pigments used in the immunological immunologic, immunological

emanating from or pertaining to immunology.


immunologic competence
see immunocompetence.

immunologic domains
 diagnostics market. Spirulina Pacifica and BioAstin are sold directly online through the Company's website, www.nutrex-hawaii.com, as well as through resellers in over 30 countries worldwide. Technical information for the Company's phycobiliproteins products is available at www.phycobiliprotein.com. Corporate data and other product information are available at www.cyanotech.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 16, 2004
Words:287
Previous Article:Sigma's Successful Momentum Continues To Build; CES 2004 Showcases Numerous New Products Based On Sigma Processors.
Next Article:Florida HealthSource Adds 25 Healthcare Providers to Fast-Growing Referral Network.
Topics:



Related Articles
Cyanotech, Paravant, and Great Lakes Reit Conference Calls to be Broadcast by Investor Broadcast Network Over the Internet.
Cyanotech Reports Third Quarter Fiscal 2001 Financial Results; Initiation of Second Clinical Trial for BioAstin Announced.
Cyanotech Announces Resignation of Ronald P. Scott as Chief Financial Officer; Jeffrey H. Sakamoto Appointed Vice President-Finance & Administration.
Cyanotech Reports Fourth Quarter and Fiscal 2003 Financial Results; Net Sales Up 18% for Fourth Quarter and 9% for Fiscal 2003.
Cyanotech Corporation Reports Second Quarter Fiscal 2004 Financial Results; Company Reports Quarter to Quarter Sales Increase of 17%.
Cyanotech Corporation Reports Third Quarter Fiscal 2004 Financial Results; Company Reports Net Income of $109,000 on Increased Sales and Improved...
Cyanotech Announces Financial Results Webcast.
Cyanotech Corporation Reports Fourth Quarter and Fiscal Year-End 2004 Financial Results; Company Reports Net Income of $399,000 for the Fiscal Year...
Cyanotech Announces Fiscal Year 2005 First Quarter Financial Results Webcast August 2, 2004.
Cyanotech Corporation Reports First Quarter Fiscal 2005 Financial Results; Reports Net Income of $113,000.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles